Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
Gupta et al., JAMA, doi:10.1001/jama.2022.2832 (results published 12/4/21)
https://c19early.org/gupta4.html